These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16018130

  • 1. Anticonvulsant drug therapies.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2005 Jun; 43(6):17-20. PubMed ID: 16018130
    [No Abstract] [Full Text] [Related]

  • 2. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
    Rosa AR, Fountoulakis K, Siamouli M, Gonda X, Vieta E.
    CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083
    [Abstract] [Full Text] [Related]

  • 3. New pharmacotherapies for pediatric seizures.
    Pellock JM.
    Pediatr Ann; 2004 Jun; 33(6):385-91. PubMed ID: 19449513
    [No Abstract] [Full Text] [Related]

  • 4. Newer anticonvulsants in the treatment of bipolar disorder.
    Yatham LN.
    J Clin Psychiatry; 2004 Jun; 65 Suppl 10():28-35. PubMed ID: 15242330
    [Abstract] [Full Text] [Related]

  • 5. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.
    Lai EC, Hsieh CY, Su CC, Yang YK, Huang CW, Lin SJ, Setoguchi S.
    Medicine (Baltimore); 2016 Aug; 95(35):e4481. PubMed ID: 27583857
    [Abstract] [Full Text] [Related]

  • 6. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
    Pinheiro D.
    Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
    [Abstract] [Full Text] [Related]

  • 7. Treating bipolar depression.
    Shelton RC.
    J Fam Pract; 2003 Mar; Suppl():S14-7. PubMed ID: 12676079
    [No Abstract] [Full Text] [Related]

  • 8. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR.
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society.
    Neurology; 2004 Apr 27; 62(8):1261-73. PubMed ID: 15111660
    [Abstract] [Full Text] [Related]

  • 10. Anticonvulsant drugs in primary headaches prophylaxis.
    Frediani F.
    Neurol Sci; 2004 Oct 27; 25 Suppl 3():S161-6. PubMed ID: 15549529
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
    Bonnett L, Smith CT, Smith D, Williamson P, Chadwick D, Marson AG.
    Lancet Neurol; 2012 Apr 27; 11(4):331-40. PubMed ID: 22377180
    [Abstract] [Full Text] [Related]

  • 12. Antidepressant properties of anticonvulsant drugs for bipolar disorder.
    Ernst CL, Goldberg JF.
    J Clin Psychopharmacol; 2003 Apr 27; 23(2):182-92. PubMed ID: 12640220
    [Abstract] [Full Text] [Related]

  • 13. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
    Yatham LN, Kusumakar V, Calabrese JR, Rao R, Scarrow G, Kroeker G.
    J Clin Psychiatry; 2002 Apr 27; 63(4):275-83. PubMed ID: 12000201
    [Abstract] [Full Text] [Related]

  • 14. Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder.
    De León OA.
    Harv Rev Psychiatry; 2001 Apr 27; 9(5):209-22. PubMed ID: 11553525
    [Abstract] [Full Text] [Related]

  • 15. Novel anticonvulsant drugs.
    Stefan H, Feuerstein TJ.
    Pharmacol Ther; 2007 Jan 27; 113(1):165-83. PubMed ID: 17030393
    [Abstract] [Full Text] [Related]

  • 16. [Empirical evidence for the use of anticonvulsants in personality disorders].
    Sieberer M, Emrich HM.
    Fortschr Neurol Psychiatr; 2009 Mar 27; 77(3):133-8. PubMed ID: 19283647
    [Abstract] [Full Text] [Related]

  • 17. Evaluating the tolerability of the newer mood stabilizers.
    Alao AO, Dewan MJ.
    J Nerv Ment Dis; 2001 Jan 27; 189(1):60-3. PubMed ID: 11206668
    [No Abstract] [Full Text] [Related]

  • 18. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Muzina DJ, Elhaj O, Gajwani P, Gao K, Calabrese JR.
    Acta Psychiatr Scand Suppl; 2005 Jan 27; (426):21-8. PubMed ID: 15833097
    [Abstract] [Full Text] [Related]

  • 19. Rethinking the treatment paradigm for bipolar depression: the importance of long-term management.
    Baldassano CF, Ballas CA, O'Reardon JP.
    CNS Spectr; 2004 Sep 27; 9(9 Suppl 9):11-8. PubMed ID: 15361807
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin.
    Sommer BR, Fenn HH, Ketter TA.
    Expert Opin Drug Saf; 2007 Mar 27; 6(2):133-45. PubMed ID: 17367259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.